Use of ipragliflozin to treat type 2 diabetes mellitus and its complications in Japanese patients.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2015
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2015 New trial record
- 09 Jun 2015 Results in 229 patients completing 12 weeks follow-up presented at the 75th Annual Scientific Sessions of the American Diabetes Association.